Beyond linearity and static risk: re-evaluating core prognostic factors in diffuse large B-cell lymphoma
- 12 March 2026
- journal article
- Published by Taylor & Francis in Expert Review of Hematology
- Vol. 19 (5) , 563-570
Abstract
This study challenges the static and linear assumptions of traditional prognostic models for diffuse large B-cell lymphoma (DLBCL), such as the International Prognostic Index (IPI). Analyzing 664 DLBCL patients treated with R-CHOP, the research explored the time-dependent and nonlinear effects of established risk factors. While the IPI maintained strong overall prognostic stability, its individual components exhibited dynamic behavior. ECOG performance score, beta-2 microglobulin (β2 M), and lactate dehydrogenase (LDH) were key predictors of early mortality, with their influence diminishing over time. Conversely, the importance of Ann Arbor stage and extranodal involvement grew, identifying them as markers of later risk. Notably, the study found a resurgence in the predictive power of β2 M after two years. Furthermore, restricted cubic spline modeling revealed significant nonlinear relationships between overall survival and age, LDH, and β2 M (all p < 0.001 for nonlinearity). The prognostic impact of baseline factors in DLBCL follows dynamic and nonlinear trajectories, challenging the one-size-fits-all approach of current risk scores. Future models should incorporate these temporal dynamics to provide a more accurate, personalized risk assessment.Keywords
This publication has 27 references indexed in Scilit:
- Non-linear relationship between soluble interleukin-2 receptor and prognosis of diffuse large B-cell lymphomaAnnals of Hematology, 2024
- Diffuse large B‐cell lymphomaHematological Oncology, 2023
- Utility of the frailty score for predicting prognosis and individualizing treatment intensity in elderly patients with diffuse large B cell lymphomaAnnals of Hematology, 2023
- The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid NeoplasmsLeukemia, 2022
- Utility of the Geriatric 8 for the Prediction of Therapy-Related Toxicity in Older Adults with Diffuse Large B-Cell LymphomaThe Oncologist, 2020
- Diffuse large B-cell lymphomaPathology, 2018
- Nomogram Predicting Prostate Cancer–specific Mortality for Men with Biochemical Recurrence After Radical ProstatectomyEuropean Urology, 2015
- Regression Modeling Strategies2015
- Diffuse large B-cell lymphomaCritical Reviews in Oncology/Hematology, 2013
- Flexible regression models with cubic splinesStatistics in Medicine, 1989